185 related articles for article (PubMed ID: 37625261)
41. [Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].
Pozo-Laderas JC; Pontes-Moreno A; Robles-Arista JC; Bautista-Rodriguez MD; Candau-Alvarez A; Caro-Cuenca MT; Linares-Sicilia MJ
Rev Iberoam Micol; 2015; 32(1):46-50. PubMed ID: 23583263
[TBL] [Abstract][Full Text] [Related]
42. Mucormycosis and COVID-19: An epidemic within a pandemic in India.
Selarka L; Sharma S; Saini D; Sharma S; Batra A; Waghmare VT; Dileep P; Patel S; Shah M; Parikh T; Darji P; Patel A; Goswami G; Shah A; Shah S; Lathiya H; Shah M; Sharma P; Chopra S; Gupta A; Jain N; Khan E; Sharma VK; Sharma AK; Chan ACY; Ong JJY
Mycoses; 2021 Oct; 64(10):1253-1260. PubMed ID: 34255907
[TBL] [Abstract][Full Text] [Related]
43. Physicians' knowledge of invasive fungal disease in China.
Chen Y; Huang X; Qiu H; Cheng L; Yu Y; Ma X; Feng S; Li Q; Wu D; Huang W; Chen D; Lv X; Hu J; Wang J; Li J; Yang W; Zhan Q; Sun B; Wang M
Mycoses; 2023 Aug; 66(8):723-731. PubMed ID: 37059587
[TBL] [Abstract][Full Text] [Related]
44. Editorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic.
Parums DV
Med Sci Monit; 2022 Dec; 28():e939088. PubMed ID: 36453055
[TBL] [Abstract][Full Text] [Related]
45. The burden of serious fungal diseases in Russia.
Klimko N; Kozlova Y; Khostelidi S; Shadrivova O; Borzova Y; Burygina E; Vasilieva N; Denning DW
Mycoses; 2015 Oct; 58 Suppl 5():58-62. PubMed ID: 26449508
[TBL] [Abstract][Full Text] [Related]
46. Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan.
Wu HY; Chang PH; Huang YS; Tsai CS; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Yang TL; Lee CY; Ho TS; Wang HW; Huang SF; Wu AY; Chen HJ; Chen YC; Chen WC; Tseng CH; Lin PC; Yang CH; Hong PL; Lee SS; Chen YS; Liu YC; Wang FD; ; ; ; ;
J Microbiol Immunol Infect; 2023 Apr; 56(2):207-235. PubMed ID: 36586743
[TBL] [Abstract][Full Text] [Related]
47. How to treat fungal infections in ICU patients.
Matthaiou DK; Christodoulopoulou T; Dimopoulos G
BMC Infect Dis; 2015 May; 15():205. PubMed ID: 25930035
[TBL] [Abstract][Full Text] [Related]
48. A Multiplex PCR and DNA-Sequencing Workflow on Serum for the Diagnosis and Species Identification for Invasive Aspergillosis and Mucormycosis.
Imbert S; Portejoie L; Pfister E; Tauzin B; Revers M; Uthurriague J; Hernandez-Grande M; Lafon ME; Jubert C; Issa N; Dumas PY; Delhaes L
J Clin Microbiol; 2023 Jan; 61(1):e0140922. PubMed ID: 36533925
[TBL] [Abstract][Full Text] [Related]
49. Treatment of invasive infections due to rare or emerging yeasts and moulds.
Sahin GO; Akova M
Expert Opin Pharmacother; 2006 Jun; 7(9):1181-90. PubMed ID: 16732704
[TBL] [Abstract][Full Text] [Related]
50. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
[TBL] [Abstract][Full Text] [Related]
51. Surge of mucormycosis during the COVID-19 pandemic.
Dam P; Cardoso MH; Mandal S; Franco OL; Sağıroğlu P; Polat OA; Kokoglu K; Mondal R; Mandal AK; Ocsoy I
Travel Med Infect Dis; 2023; 52():102557. PubMed ID: 36805033
[TBL] [Abstract][Full Text] [Related]
52. Impact of COVID-19 pandemic on antifungal consumption: a multicenter retrospective analysis.
Bienvenu AL; Bestion A; Pradat P; Richard JC; Argaud L; Guichon C; Roux S; Piriou V; Paillet C; Leboucher G;
Crit Care; 2022 Dec; 26(1):384. PubMed ID: 36514110
[TBL] [Abstract][Full Text] [Related]
53. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India.
Aranjani JM; Manuel A; Abdul Razack HI; Mathew ST
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009921. PubMed ID: 34793455
[TBL] [Abstract][Full Text] [Related]
54. Rhino-Orbital Mucormycosis in a COVID-19 Patient: A Dreadful Challenge.
Dhakal A; Pokharel M; Madhup S; Khadka L; Sapkota B
Kathmandu Univ Med J (KUMJ); 2022; 20(78):249-251. PubMed ID: 37017177
[TBL] [Abstract][Full Text] [Related]
55. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
56. Pathogenesis of Respiratory Viral and Fungal Coinfections.
Salazar F; Bignell E; Brown GD; Cook PC; Warris A
Clin Microbiol Rev; 2022 Jan; 35(1):e0009421. PubMed ID: 34788127
[TBL] [Abstract][Full Text] [Related]
57. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis.
Ahmadikia K; Hashemi SJ; Khodavaisy S; Getso MI; Alijani N; Badali H; Mirhendi H; Salehi M; Tabari A; Mohammadi Ardehali M; Kord M; Roilides E; Rezaie S
Mycoses; 2021 Aug; 64(8):798-808. PubMed ID: 33590551
[TBL] [Abstract][Full Text] [Related]
58. Secondary fungal infections in SARS-CoV-2 patients: pathological whereabouts, cautionary measures, and steadfast treatments.
Singh R; Malik P; Kumar M; Kumar R; Alam MS; Mukherjee TK
Pharmacol Rep; 2023 Aug; 75(4):817-837. PubMed ID: 37354313
[TBL] [Abstract][Full Text] [Related]
59. Invasive fungal infections in critically ill patients: A prospective study from a tertiary care hospital in India.
Durga CS; Gupta N; Soneja M; Bhatt M; Xess I; Jorwal P; Singh G; Ray A; Nischal N; Ranjan P; Biswas A; Wig N
Drug Discov Ther; 2018; 12(6):363-367. PubMed ID: 30674771
[TBL] [Abstract][Full Text] [Related]
60. Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients.
Basile K; Halliday C; Kok J; Chen SC
J Fungi (Basel); 2022 Jan; 8(1):. PubMed ID: 35049999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
